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Respiratory sleep disorders are strongly associated with upper airway patency. Nasal obstruction 
is associated with higher incidences of sleep apnea, primarily by increasing the negative pressure 
on the airway during inspiration. 
Aims: To evaluate the influence of nasal obstruction in the worsening of sleep apnea in patients 
with OSA and a high score on the modified classification of Mallampati. 
Materials and Methods: We evaluated and classified 206 patients complaining of snoring, and with 
a past suggestive of OSA through the Modified Mallampati score, Friedman, nasal obstruction and 
the severity of OSA by AHI. 
Results: 168 patients who underwent polysomnography were included. Cross-plotting was made 
comparing the modified Mallampati score, nasal obstruction and AIH. The odds ratio between high 
Mallampati score and AHI was OR = 5.053, 95% CI = 1.458 to 7.517 (p = 0.0071). High Mallampati 
score associated with nasal obstruction was correlated with OSAS (p = 0.0227). However the influence 
of nasal obstruction on the relationship of high Mallampati score and OSA was not significant: OR 
= 2.850, 95% CI = 0.992 to 8.189. 
Conclusion: The combination of high Mallampati score and nasal obstruction represents a greater 
risk factor for worsening of OSA. 
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INTRODUCTION
Respiratory sleep disorders are associated with 
upper airway obstruction. Described in 1973 by Cristian 
Guilleminault1, the Sleep Obstructive Apnea Syndrome 
(SOAS) is a disease characterized by airway obstruction du-
ring sleep, causing apnea associated with chest respiratory 
effort1. Clinical manifestation is variable, more prevalent 
among obese men with large neck circumference2.
A recent epidemiological study carried out in São 
Paulo - Brazil shows that the prevalence of SOAS is of 
32.8% in the adult population of this city. The risk factors 
associated with the syndrome development were: male 
gender, Body Mass Index (BMI) > 25kg/m2, low socioeco-
nomic status, advanced age and women at menopause. 3
Since its discovery, SOAS has been broadly studied 
and it proved to be a disease which is extremely important 
and prevalent. It is important because it is brings about 
relevant morbidity, association with numerous diseases, 
such as coronary disease4, stroke5, dyslipidemia and dia-
betes mellitus4. It is prevalent because it affects 32.8% 
of the population6,3; however, it is estimated that it is a 
highly underdiagnosed disease7. About 20% of the adult 
population report snoring and 95% of the patients with 
SOAS complain of snoring8.
Risk factors for sleep apnea and snoring are pre-
sent in patients between 40 and 65 years, most of them 
males, obese, smokers, drinkers and sedentary9. The main 
physical findings include an enlargement of the neck cir-
cumference, oropharyngeal obstruction, soft palate laxity, 
nasal obstruction, turbinate hypertrophy, nasal septum 
deformity, nasal cavity tumors, tonsil hypertrophy, macro-
glossy, retrognatia and temporomandibular deformities10.
It is extremely important to fully assess the upper 
airways when assessing a patient with SOAS, especially 
the nasal cavity. Nasal obstruction is associated with an 
increase in sleep apnea, especially because of an increa-
se in the negative pressure caused to the airways during 
inspiration11.
OBJECTIVES
To assess the influence of nasal obstruction asso-
ciated with the modified Mallampati classification in SOAS 
severity.
MATERIALS AND METHODS
This study was approved by the Ethics in Research 
Committee, under protocol # 112/08 and it was duly re-
gistered in the Clinical Trials Registry. 206 snoring patients 
and clinical history suggesting sleep apnea were assessed 
in the SOAS Ward, with symptoms of daytime sleepiness, 
unrestorative sleep, nasal obstruction and snoring. The 
sample had 110 men (53%) and 96 women (47%). All 
the patients were submitted to an assessment protocol 
including interview, Epworth’s scale, Stanford snoring 
scale, Friedman’s classification and complete ENT exam - 
including oral exam, patients classification according to the 
modified Mallampati score and anterior rhinoscopy, later 
confirmed by nasal fibroscopy, defining septal deviations 
and inferior turbinate hypertrophy.
The Epworth’s scale is broadly used to assess the 
degree of daytime sleepiness, being made up of eight 
questions about the person’s level of daytime sleepiness 
in given daily activities. The scale goes from 0 to 24: 
daytime sleepiness is considered when the score is higher 
than 10 points12. The Friedman scale is used to assess oro-
pharyngeal obstruction evaluating tonsil size by means of 
the Modified Mallampati Classification and BMI - varying 
between I and IV13.
The patients were submitted to nasofibroscopy with 
the 3.2mm Machida ENT-30 PIII flexible scope in order to 
assess the level of upper airway obstruction. Nasal sep-
tum deviation and/or inferior turbinate hypertrophy were 
confirmed by nasal fibroscopy done under a spray of 2% 
lidocaine in each of the nostrils without vasoconstriction 
in order not to have a biased evaluation. All patients were 
offered a 30-day oral antihistaminic treatment and topical 
nasal steroid for 03 months.
Afterwards, all the patients were referred for noc-
turnal polysomnography at the sleep laboratory, with full 
monitoring of the following parameters: electro-oculogram, 
leg electromyography, air flow, chest and abdominal mo-
vement, EEG, EKG, heart rate and oxygen saturation. The 
patients were distributed according to disease severity and 
according to the criteria established by the American Sleep 
Academy Task-Force1.
Exclusion Criteria
Patients with the following conditions were taken 
off this study:
• Morbid obesity (BMI>40);
• Craniofacial abnormalities: cranio-dysostosis, 
craniostenosis and meningomyelocele;
• Nasal obstruction due to polyposis;
• Nasal obstruction due to nasal tumors;
Statistics
Of the 206 patients assessed according to the pro-
tocol, 168 patients were included. The remaining patients 
matched 1 or more exclusion criteria.
Based on the Sleep Hypopnea-Apnea Index (HAI), 
considered the outcome variable of the model, the valid 
sample was later broken down into two groups: Group 
I with patients with primary snoring or mild SOAS (HAI 
≤ 15 events/hour) and Group II with moderate to severe 
SOAS patients (HAI > 15 events/hour). We first selected 
the variables and, based on the results, we selected the 
following variables:
1. Modified Mallampati classification with the same 
criteria used in the Friedman classification14. The patients 
were broken down into two groups: patients with low 
Mallampati score (1-2) and those with high Mallampati 
score (3-4).
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2. As to the presence of nasal obstruction, the pa-
tients were broken down into two groups. We included 
those patients with nasal septum deviation and/or inferior 
turbinate hypertrophy, after the treatment of the nasal ato-
py described above. Therefore, patients with nasal polyps 
and those with nasal tumors were excluded.
In order to analyze the data, we used the logistic 
function (PROC LOGISTIC) from the SAS software, as su-
ggested by Allison14. We also used the SAS/STAT function 
(SAS INSTITUTE, 2001), in accordance with the routine 
presented by Stokes15. The model adjustment was asses-
sed by the AIC and -2 Log L criteria, and the statistical 
significance evaluation of the estimated parameters was 
carried out by the maximum similarity ratio. We included 
in the study the interaction effect between the Mallampati 
variables and Nasal Obstruction - for it proved significant 
- in an attempt to understand its behavior.
RESULTS
Table 2 shows the analysis of the effects studied ba-
sed on the Chi-square significance test. We associated the 
variable studied with the HAI higher than 15 events/hour.
The Mallampati modified classification is positively 
associated with the HAI (p = 0.0071). The nasal obstruction 
alone is not associated with the HAI (p= 0.6670). When 
analyzed as factors associated with the High Mallampati 
score and Nasal Obstruction, they were positively asso-
ciated with the HAI (p=0.0227).
As far as the other variables analyzed are concerned, 
BMI, Epworth’s Scale and Male gender were statistically 
associated with the HAI. Since almost the entire sample 
complained of snoring, such variable was not positively 
associated with the HAI.
Since the Mallampati and nasal obstruction inte-
raction was significant (p<0.05), we analyzed how the 
Mallampati score interacted with Nasal Obstruction. Thus, 
we unfolded the interaction, adjusting a model with the 
Mallampati effect within each Nasal Obstruction level and 
a model with the Nasal Obstruction variable within each 
Mallampati level. The results are presented on Table 3. 
This table shows the Mallampati and Nasal Obstruc-
tion interaction, and the analysis had HAI > 15 events/
hour as dependant variable. The risk of a patient having 
severe SOAS is greater when there is High Mallampati in 
the absence of Nasal Obstruction (OR=5.053, CI 95%=1.458 
- 7.517). When we assessed the presence of high Mallam-
pati and Nasal Obstruction, the OR was 2.850 (CI 95% = 
0.992 - 8.189) and 2.27 (CC 95% = 0.728 - 7.076) with mild 
Mallampati and nasal obstruction.
There was no statistical significance in the analysis 
of the nasal obstruction influence on the Mallampati score 
correlation, in other words, nasal obstruction does not 
interfere in the interaction between the Mallampati score 
and the HAI > 15 events/hour; nonetheless, the association 
of both variables was positive (p=0.0227).
Table 1. Distribution of the Variables in the SOAS Protocol. 
 STANFORD BMIa EPWORTH AGE
Mean  8.16 29.42 11.25 47.95
Standard 
Deviation
 2.10 5.55 5.14 11.25
Minimum  2 16.44 0 17
Maximum  10 51.02 24 77
a Body Mass Index 
Table 2. SOAS Protocol Variables in relation to a HAI >15 events/
hour.
Variable p (Chi-square Test)
High Mallampati 0,0071(s)
BMIa > 25kg/m2 0,0043(s)
Epworth > 10 pts 0,0064(s)
Snoring 0,4565(ns)
Nasal Obstruction 0,6670(ns)
High Mallampati associated 
with Nasal Obstruction
0,0227(s)
Male Gender 0,0021(s)
a Body Mass Index
Table 3. Interaction of the different levels of the Mallampati score 
and Nasal Obstruction with an HAI > 15 events/hour.
Mallampati Nasal Obstruction OR CI 95%
Low No 1.00 -
Low Yes 2.270 0.728 - 7.076(ns)
High Yes 2.850 0.992 - 8.189(ns)
High No 5.053 1.458 - 7.517(s)
OR: “Odds Ratio”
CI 95%: Confidence Interval
DISCUSSION
SOAS is a disease which mainly affects the upper 
airways (UAW), and it can be caused by obstruction of 
numerous structures such as the palate, nasal septum de-
viation, elongated uvula, palatine tonsil, macroglossy and 
posterior pharyngeal wall. Each point can have a different 
impact on the UAW obstruction and in different degrees 
in different patients10. It is an important disease in the 
current medical setting because of its association of high 
incidence and comorbidity3.
In our sample, the male gender was positively corre-
lated with the presence of SOAS, corroborating numerous 
populational studies carried out in Brazil3, the United States 
and Europe2. Men tend to be more obese, have a thicker 
neck and a greater likelihood of having UAW obstruction 
during sleep.
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Obesity represented by a BMI > 25Kg/m2 is asso-
ciated with SOAS in different levels. The higher the BMI, 
the greater the HAI tended to be in our sample. By the 
same token, the Epworth Sleepiness Scale is significantly 
correlated with the HAI, showing that excess day-time sle-
epiness is an important symptom and must be extensively 
evaluated in SOAS predisposition assessment.
The influence of the high Mallampati score on sleep 
respiratory disorders, especially SOAS, is very important 
and it is described in numerous studies17. Patients with a 
high Mallampati score tend to have obstruction, especially 
because of macroglossia, precluding air passage from the 
nose and mouth to the lower airways (LAW).
By the same token, the association of SOAS and 
nasal obstruction has been broadly studied in the last two 
decades18. Udaka et al.19 showed, by means of a popu-
lational study with 4,818 patients, a positive correlation 
between nasal obstruction, daytime sleepiness and sleep 
apnea. Patients with nasal obstruction tend to have grea-
ter negative pressure, thus causing UAW obstruction and 
consequently oxygen desaturation and increase in chest 
stress10. In our series, the presence of nasal obstruction 
alone was not statistically associated with SOAS.
The presence of a high Mallampati score associa-
ted with nasal obstruction increases the likelihood of the 
patient developing apnea and its consequent worsening. 
Patients with such conditions have two important obstruc-
tion points, increasing SOAS severity because the patient 
would put up a greater chest stress in order to overcome 
two levels of obstruction18.
We observed that in a series of patients with High 
Mallampati score, that it is an important isolated risk factor 
for apnea appearance and worsening.
The association between a high Mallampati score 
and Nasal Obstruction is a risk factor for the development 
and worsening of apnea. The two variables, when asso-
ciated, are statistically correlated with the apnea severity. 
However, nasal obstruction does not impact on the corre-
lation between a high Mallampati score and HAI, therefore 
not causing additional risk to the worsening of the apnea 
in this subpopulation.
Surgical planning and the careful assessment of 
SOAS patients are fundamental in order to establish the 
different obstructive anatomical sites. Patients with high 
Mallampati score tend to have a high Friedman score and 
a lower uvulopalatopharyngoplasty success13. Patients with 
such condition associated with nasal obstruction must 
be better assessed, since one can reduce the severity of 
apnea with the correction of the nasal obstruction, either 
clinically or surgically.
In the cases of nasal surgery in apneic patients, 
in our service we prefer the conventional nasal septum 
surgery and partial turbinectomy without the use of nasal 
packing, for having less comorbidity and lower immediate 
post-operative complication rates, which is usually critical 
to these patients. There are reports of the use of turbinec-
tomy by radiofrequency with lower postoperative morbidi-
ty, less edema and lower risks of bleeding and sinechia20.
CONCLUSION
The high Mallampati score is an important isolated 
risk factor for the worsening of the apnea. Nasal Obstruc-
tion becomes an important additional risk factor when 
associated to apneic patients with a high Mallampati score. 
Nasal obstruction alone is not associated with SOAS. No-
netheless, we stress the relevance of a careful assessment 
of the UAW and its possible points of obstruction in the 
evaluation and surgical planning of patients with sleep 
apnea.
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